跳至主要内容
临床试验/EUCTR2017-001024-21-IT
EUCTR2017-001024-21-IT进行中(未招募)1 期

innovative model for the eradication of HCV in a population at high risk of irregular immigrants and low-income refugees - Eradication of HCV infection in immigrants subject

A.O.U. Università degli Studi della Campania Luigi Vanvitelli0 个研究点目标入组 6,000 人开始时间: 2021年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects illegal immigrants, refugees or asylum seekers in Italy for at least three months, observed for the first time or already known from our center, with HCV infection and who have signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5000
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1000

排除标准

  • Subjects indigenous or registered refugees

研究者

发起方
A.O.U. Università degli Studi della Campania Luigi Vanvitelli

相似试验